Memorial Delirium Assessment Scale [MDAS-10]

Description and Purpose

The Memorial Delirium Assessment Scale (MDAS-10) is an assessment instrument used for the detection and evaluation of delirium in patients. According to the source document, it is commonly applied in clinical settings such as intensive care units (ICUs) and palliative care, and it contributes to the assessment of delirium severity and prognosis.

The instrument provides a structured approach to evaluating several clinical manifestations associated with delirium, allowing healthcare professionals to quantify the severity of symptoms and monitor changes in a patient’s condition.

Structure of the Scale

The MDAS consists of 10 assessment domains, each addressing a different aspect of delirium. According to the uploaded document, these include:

Level of Consciousness: Assesses the patient’s alertness and ability to maintain attention.

Comprehension: Evaluates the patient’s ability to understand and respond to questions or instructions.

Language Disturbances: Examines difficulties involving speech, expression, or comprehension.

Sleep Disturbances: Assesses changes in the patient’s usual sleep patterns.

Disturbances of Thought and Perception: Evaluates the presence of delusional or hallucinatory experiences as described in the source material.

Memory Impairment: Examines the extent of memory difficulties or amnesia.

Confusion: Assesses the degree of confusion experienced by the patient.

Agitation: Evaluates the presence of anxiety, restlessness, or agitation.

Unusual Behaviors: Assesses the presence of unusual or unpredictable behavioral manifestations.

Emotional Stability: Examines the patient’s emotional responses across different situations.

Assessment Objectives

The primary objective of the MDAS is to detect and assess the severity of delirium.

According to the source document, the scale has three principal objectives: detecting and evaluating delirium severity, assisting in the management of delirium, and monitoring its progression and the patient’s response to treatment.

Its structured scoring system allows repeated assessments to be performed, making it possible to compare symptom severity across different time points.

Administration and Scoring

The MDAS is completed by an examiner, who evaluates the patient across the 10 domains.

Each domain is rated on a scale ranging from 0 to 3, with higher scores indicating more severe symptoms. The individual scores are then summed to generate an overall score reflecting the severity of delirium.

Based on the scoring structure described in the source document, the total theoretical score ranges from 0 to 30.

Higher total scores represent greater symptom severity. Interpretation should be conducted according to the procedures and criteria established for the particular version of the scale being used.

Data Analysis and Use

In research settings, the MDAS total score can be analyzed as a quantitative indicator of delirium severity.

Descriptive statistics such as the mean, standard deviation, median, and range may be calculated to summarize the distribution of scores within a study population.

When repeated measurements are available, changes in MDAS scores can be examined over time to investigate the progression of delirium or changes during treatment.

Depending on the research design, MDAS scores may also be examined in relation to demographic or clinical variables included in the study.

Reliability and Validity

Psychometric evaluation of the MDAS may involve examining properties such as internal consistency, inter-rater agreement, validity, and sensitivity to changes in symptom severity.

However, the uploaded source document does not provide specific numerical reliability coefficients, validity indices, or diagnostic cut-off values for the scale. Therefore, such values should not be inferred from the available material.

The psychometric characteristics and interpretation criteria should be considered according to the particular version of the MDAS and the clinical population in which it is administered.

Applications

The MDAS can be applied in clinical and research settings requiring systematic evaluation of delirium severity.

According to the source document, its applications include detecting and assessing delirium, assisting in clinical management, and monitoring changes in the patient’s condition over time.

Its structured scoring system can facilitate repeated assessments and quantitative comparisons of symptom severity at different stages of care.

The MDAS should be used as part of a broader clinical assessment rather than as an isolated source of information about a patient’s condition.

Conclusion

The Memorial Delirium Assessment Scale [MDAS-10] provides a structured method for assessing and quantifying the severity of delirium-related manifestations.

By evaluating 10 clinical domains, each scored from 0 to 3, the instrument generates an overall measure of symptom severity. This structure makes the MDAS particularly useful for both initial assessment and repeated monitoring of delirium over time.

References

McNicoll, L., Inouye, S. K., Jones, R., & Fridman, C. (2003). The Memorial Delirium Assessment Scale: A new tool for assessing delirium. Journal of Palliative Medicine, 6(4), 617–624.

Inouye, S. K., van Dyck, C. H., Alessi, C. A., Balkin, S., Siegal, A., & Horwitz, R. I. (1990). The Confusion Assessment Method: A new method for detecting delirium. JAMA, 263(20), 3216–3221.

Borson, S., Scanlan, J. M., Watanabe, J., & Tu, S. P. (2003). The Mini-Cog: A cognitive tool for dementia screening in multi-lingual elderly. Journal of the American Geriatrics Society, 51(5), 679–687.